Abbott Launches XIENCE Skypoint in India, Resolves $40 M Legal Settlement & Drives Digital Diagnostics Growth
Abbott Laboratories launches its XIENCE Skypoint cardiovascular platform in India, ending a 3‑year litigation saga and advancing digital diagnostics with ICRAS – a strategic shift toward high‑growth tech solutions and regulatory clarity.
3 minutes to read









